Literature DB >> 27429850

Association of human papillomavirus, Neisseria gonorrhoeae and Chlamydia trachomatis co-infections on the risk of high-grade squamous intraepithelial cervical lesion.

André Lp de Abreu1, Natália Malaguti2, Raquel P Souza2, Nelson S Uchimura3, Érika C Ferreira4, Monalisa W Pereira2, Maria Db Carvalho3, Sandra M Pelloso5, Marcelo G Bonini6, Fabrícia Gimenes2, Marcia El Consolaro2.   

Abstract

The link between high-risk human Papillomavirus (HR-HPV) and other sexually transmitted diseases (STDs) in the risk of developing cervical cancer still unclear. Thus, in this report we investigated the rates of co-infections between HPV and other important non-HPV STDs in different cervical findings using a multiplex polymerase chain reaction (M-PCR) to simultaneously detect Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Trichomonas vaginalis, HSV-1 and -2, and Treponema pallidum. A total of 838 women aged 18 to 68 years were screened using Papanicolaou smears for cervical abnormalities, HPV and non-HPV STDs using PCR and M-PCR methods. A total of 614 (73.3%) of the women had normal cytology (NILM) and 224 (26.7%) women exhibited abnormal cytology (≥ ASC-US). HPV-DNA prevalence was 33.9%, and HPV-16 was the most prevalent genotype in women with NILM and ≥ ASC-US cytology. Non-HPV STDs were detected in 30.4% women and T. vaginalis was the most prevalent one (11.6%). A higher increased risk of ≥ ASC-US and HSIL occurred in co-infections of HR-HPV with C. trachomatis and N. gonorrhoeae. Co-infections of HPV-DNA and HR-HPV with HSV-2 exhibited a similar increased risk but only with ≥ ASC-US. Co-infections of HPV-DNA and HR-HPV with T. vaginalis demonstrated a similar increased risk of ≥ ASC-US and HSIL. We found that C. trachomatis and N. gonorrhoeae were the primary pathogens associated with HR-HPV for the increased risk for all grades of cervical abnormalities but mainly for HSIL, suggesting a possible synergistic action in cervical lesions progression. Our results reinforce the hypothesis that some non-HPV STDs might play a role as co-factors in HPV-mediated cervical carcinogenesis. These data improve our understanding of the etiology of SCC and may also be useful for disease prevention.

Entities:  

Keywords:  Cervical cancer; HPV; HSIL; co-factors; progression risk; sexually transmitted diseases

Year:  2016        PMID: 27429850      PMCID: PMC4937739     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  36 in total

1.  An association between Trichomonas vaginalis and high-risk human papillomavirus in rural Tanzanian women undergoing cervical cancer screening.

Authors:  Gweneth B Lazenby; Peyton T Taylor; Barbara S Badman; Emil McHaki; Jeffrey E Korte; David E Soper; Jennifer Young Pierce
Journal:  Clin Ther       Date:  2014-01-01       Impact factor: 3.393

2.  Evaluation of a new multiplex polymerase chain reaction assay STDFinder for the simultaneous detection of 7 sexually transmitted disease pathogens.

Authors:  Claude Mambo Muvunyi; Nathalie Dhont; Rita Verhelst; Tania Crucitti; Martin Reijans; Brit Mulders; Guus Simons; Marleen Temmerman; Geert Claeys; Elizaveta Padalko
Journal:  Diagn Microbiol Infect Dis       Date:  2011-07-27       Impact factor: 2.803

3.  Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study.

Authors:  Victor Moreno; F Xavier Bosch; Nubia Muñoz; Chris J L M Meijer; Keerti V Shah; Jan M M Walboomers; Rolando Herrero; Silvia Franceschi
Journal:  Lancet       Date:  2002-03-30       Impact factor: 79.321

4.  An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV).

Authors:  P E Castle; S L Hillier; L K Rabe; A Hildesheim; R Herrero; M C Bratti; M E Sherman; R D Burk; A C Rodriguez; M Alfaro; M L Hutchinson; J Morales; M Schiffman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-10       Impact factor: 4.254

5.  Human Papillomaviruses and genital co-infections in gynaecological outpatients.

Authors:  Rosita Verteramo; Alessandra Pierangeli; Emanuela Mancini; Ettore Calzolari; Mauro Bucci; John Osborn; Rosa Nicosia; Fernanda Chiarini; Guido Antonelli; Anna Marta Degener
Journal:  BMC Infect Dis       Date:  2009-02-12       Impact factor: 3.090

6.  Herpes simplex virus type II is not a cofactor to human papillomavirus in cancer of the uterine cervix.

Authors:  Danh Tran-Thanh; Diane Provencher; Anita Koushik; Eliane Duarte-Franco; Allégria Kessous; Pierre Drouin; Cosette M Wheeler; Josée Dubuc-Lissoir; Philippe Gauthier; Guy Allaire; René Vauclair; Joseph A Dipaolo; Patty Gravitt; Eduardo Franco; Francois Coutlée
Journal:  Am J Obstet Gynecol       Date:  2003-01       Impact factor: 8.661

7.  Molecular detection of HPV and Chlamydia trachomatis infections in Brazilian women with abnormal cervical cytology.

Authors:  André L P de Abreu; Paula R B Nogara; Raquel P Souza; Mariana C da Silva; Nelson S Uchimura; Rodrigo L Zanko; Erika C Ferreira; Maria C B Tognim; Jorge J V Teixeira; Fabrícia Gimenes; Marcia E L Consolaro
Journal:  Am J Trop Med Hyg       Date:  2012-11-05       Impact factor: 2.345

8.  Impact of human papillomavirus coinfections on the risk of high-grade squamous intraepithelial lesion and cervical cancer.

Authors:  Adela Carrillo-García; Sergio Ponce-de-León-Rosales; David Cantú-de-León; Verónica Fragoso-Ontiveros; Imelda Martínez-Ramírez; Asunción Orozco-Colín; Alejandro Mohar; Marcela Lizano
Journal:  Gynecol Oncol       Date:  2014-06-27       Impact factor: 5.482

9.  Relationship between cervical disease and infection with human papillomavirus types 16 and 18, and herpes simplex virus 1 and 2.

Authors:  Youyun Zhao; Xuan Cao; Yi Zheng; Jingfeng Tang; Wangxi Cai; Hanmin Wang; Yinglin Gao; Yefu Wang
Journal:  J Med Virol       Date:  2012-12       Impact factor: 2.327

Review 10.  Management of women with cervicitis.

Authors:  Jeanne M Marrazzo; David H Martin
Journal:  Clin Infect Dis       Date:  2007-04-01       Impact factor: 9.079

View more
  19 in total

Review 1.  Cervical Cancer Induction Enhancement Potential of Chlamydia Trachomatis: A Systematic Review.

Authors:  Safae Karim; Tiatou Souho; Mohamed Benlemlih; Bahia Bennani
Journal:  Curr Microbiol       Date:  2018-01-22       Impact factor: 2.188

2.  Genital Tract Infections in an Isolated Community: 100 Women of the Príncipe Island.

Authors:  Pedro Vieira-Baptista; Svitrigaile Grinceviciene; Gert Bellen; Carlos Sousa; Conceição Saldanha; Davy Vanden Broeck; John-Paul Bogers; Gilbert Donders
Journal:  Infect Dis Obstet Gynecol       Date:  2017-11-13

3.  Epidemiological investigation of the relationship between common lower genital tract infections and high-risk human papillomavirus infections among women in Beijing, China.

Authors:  Dai Zhang; Ting Li; Lei Chen; Xiaosong Zhang; Gengli Zhao; Zhaohui Liu
Journal:  PLoS One       Date:  2017-05-22       Impact factor: 3.240

4.  Mycoplasma hominis and Mycoplasma genitalium in the Vaginal Microbiota and Persistent High-Risk Human Papillomavirus Infection.

Authors:  Sally N Adebamowo; Bing Ma; Davide Zella; Ayotunde Famooto; Jacques Ravel; Clement Adebamowo
Journal:  Front Public Health       Date:  2017-06-26

5.  Association between asymptomatic sexually transmitted infections and high-risk human papillomavirus in cervical lesions.

Authors:  Lei Wang; Lizhe Zhu; Han Li; Nan Ma; Huifang Huang; Xiaoling Zhang; Ying Li; Jing Fang
Journal:  J Int Med Res       Date:  2019-09-18       Impact factor: 1.671

6.  Predictors of HPV incidence and clearance in a cohort of Brazilian HIV-infected women.

Authors:  Ana Gabriela Travassos; Eduardo Netto; Eveline Xavier-Souza; Isabella Nóbrega; Karina Adami; Maiara Timbó; Karen Abbehusen; Sheyla Fernandes; Camila Duran; Tatiana Haguihara; Fábio Ferreira; Carlos Brites
Journal:  PLoS One       Date:  2017-10-05       Impact factor: 3.240

7.  Human Leukocyte Antigen Class I and Class II Polymorphisms and Serum Cytokine Profiles in Cervical Cancer.

Authors:  Larissa Bahls; Roger Yamakawa; Karina Zanão; Daniela Alfieri; Tamires Flauzino; Francieli Delongui; André de Abreu; Raquel Souza; Fabrícia Gimenes; Edna Reiche; Sueli Borelli; Marcia Consolaro
Journal:  Int J Mol Sci       Date:  2017-08-31       Impact factor: 5.923

8.  Associations of sexually transmitted infections and bacterial vaginosis with abnormal cervical cytology: A cross-sectional survey with 9090 community women in China.

Authors:  Wu Li; Lan-Lan Liu; Zhen-Zhou Luo; Chun-Yan Han; Qiu-Hong Wu; Li Zhang; Li-Shan Tian; Jun Yuan; Tao Zhang; Zhong-Wei Chen; Tu-Bao Yang; Tie-Jian Feng; Min Zhang; Xiang-Sheng Chen
Journal:  PLoS One       Date:  2020-03-26       Impact factor: 3.240

9.  Association of sexually transmitted infections and human papillomavirus co-infection with abnormal cervical cytology among women in Saudi Arabia.

Authors:  H J Alotaibi; F N Almajhdi; A N Alsaleh; D A Obeid; H H Khayat; T A Al-Muammer; A M Tulbah; M B Alfageeh; M N Al-Ahdal; F S Alhamlan
Journal:  Saudi J Biol Sci       Date:  2020-03-19       Impact factor: 4.219

10.  Prevalence of human papillomavirus (HPV) in Brazil: A systematic review and meta-analysis.

Authors:  Verônica Colpani; Frederico Soares Falcetta; Augusto Bacelo Bidinotto; Natália Luiza Kops; Maicon Falavigna; Luciano Serpa Hammes; Adele Schwartz Benzaken; Ana Goretti Kalume Maranhão; Carla Magda Allan S Domingues; Eliana Márcia Wendland
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.